Loading...

Home
ETF
ORGO

ORGO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ORGO News

Organogenesis Holdings Reports Q1 2026 Earnings with Significant Revenue Decline

3d agoseekingalpha

Organogenesis Q1 Earnings Miss Expectations with Significant Revenue Decline

4d agoseekingalpha

Organogenesis Completes BLA Submission for ReNu Therapy

Apr 29 2026NASDAQ.COM

Organogenesis Completes BLA Submission for ReNu® Allograft

Apr 28 2026Newsfilter

Organogenesis Completes PuraPly AM Clinical Trial for Diabetic Foot Ulcers

Apr 07 2026NASDAQ.COM

Organogenesis Shares Surge 29% After Successful Clinical Trial for PuraPlyAM

Apr 07 2026seekingalpha

Organogenesis Completes PuraPly®AM Clinical Trial with Significant Results

Apr 06 2026Newsfilter

Organogenesis Shares Surge After FDA Meeting on ReNu Approval

Apr 06 2026stocktwits

Organogenesis Completes FDA Meeting, Plans BLA Submission

Apr 06 2026Newsfilter

Organogenesis Holdings Inc. to Begin Rolling BLA for Renu After Positive FDA Meeting

Apr 06 2026moomoo

Organogenesis to Report Q1 2026 Financial Results on May 7

Apr 06 2026Newsfilter

Organogenesis Reports Record Q4 2025 Earnings Amid Market Uncertainty

Feb 27 2026seekingalpha

Pomerantz LLP Investigates Securities Fraud Claims Against Organogenesis Holdings

Feb 03 2026Globenewswire

Pomerantz LLP Investigates Securities Fraud Claims Against Organogenesis Holdings Inc.

Jan 22 2026PRnewswire

Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%

Jan 08 2026PRnewswire

Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%

Jan 06 2026Globenewswire